1024 GMT - Novo Nordisk will further scale up its production, supply and employment to drive innovation, its executive vice president for Commercial Strategy & Corporate Affairs, Camilla Sylvest, tells Bloomberg TV at the World Economic Forum in Davos, Switzerland. Innovation is key to compete with other players, Sylvest says when asked about industry peers grappling with patent losses by the end of the decade. "It's a big task, that's why you see us continue to scale both in production, product supply, bringing those treatment to patients, but also in terms of the number of people we employ in our company," Sylvest says. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
January 22, 2025 05:24 ET (10:24 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。